Insightful Word
  • Investing
  • Stock
  • Economy
  • Politics
  • Investing
  • Stock
  • Economy
  • Politics
No Result
View All Result
Insightful Word
No Result
View All Result
Home Stock

Cintas earnings beat by $0.08, revenue was in line with estimates

admin by admin
December 19, 2024
in Stock
0
Cintas earnings beat by $0.08, revenue was in line with estimates
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

Investing.com – Cintas (NASDAQ: CTAS) reported fourth quarter EPS of $1.09, $0.08 better than the analyst estimate of $1.01. Revenue for the quarter came in at $2.56B versus the consensus estimate of $2.56B.

Guidance

Cintas sees FY 2025 EPS of $4.28-$4.34 versus the analyst consensus of $4.24.

Cintas’s stock price closed at $204.39. It is up 0.11% in the last 3 months and up 47.66% in the last 12 months.

Cintas saw 6 positive EPS revisions and 3 negative EPS revisions in the last 90 days. See Cintas’s stock price’s past reactions to earnings here.

According to InvestingPro, Cintas’s Financial Health score is “good performance”.

Check out Cintas’s recent earnings performance, and Cintas’s financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar

This post appeared first on investing.com

Previous Post

Factbox-European companies cut jobs as economy sputters

Next Post

Roche’s Parkinson’s drug misses main goal in mid-stage trial

admin

admin

Next Post
Roche’s Parkinson’s drug misses main goal in mid-stage trial

Roche’s Parkinson’s drug misses main goal in mid-stage trial

Trending News

Top 2 crypto mining stocks to buy as analyst forecasts Bitcoin hitting $200,000

Top 2 crypto mining stocks to buy as analyst forecasts Bitcoin hitting $200,000

November 17, 2024
European pharma stocks fall on Wednesday ahead of ‘Liberation Day’ announcements: what’s at stake?

European pharma stocks fall on Wednesday ahead of ‘Liberation Day’ announcements: what’s at stake?

April 2, 2025
Exclusive-Kennedy played key role in vaccine case against Merck

Exclusive-Kennedy played key role in vaccine case against Merck

January 18, 2025
Subscribe to Insightful Word


    Recent News

    Citi raises McDonald’s price Target to $381, sees growth ahead

    Citi raises McDonald’s price Target to $381, sees growth ahead

    September 17, 2025
    Nio stock price forecast: why it is soaring and what next

    Nio stock price forecast: why it is soaring and what next

    September 17, 2025
    Nvidia CEO Jensen Huang disappointed at China ban, acknowledges geopolitcal pressures

    Nvidia CEO Jensen Huang disappointed at China ban, acknowledges geopolitcal pressures

    September 17, 2025
    US stocks flat at open ahead of Fed decision: Nasdaq slips 0.1%, Dow up 150 pts

    US stocks flat at open ahead of Fed decision: Nasdaq slips 0.1%, Dow up 150 pts

    September 17, 2025

    Recent News

    Citi raises McDonald’s price Target to $381, sees growth ahead

    Citi raises McDonald’s price Target to $381, sees growth ahead

    September 17, 2025
    Nio stock price forecast: why it is soaring and what next

    Nio stock price forecast: why it is soaring and what next

    September 17, 2025

    Latest News

    • Citi raises McDonald’s price Target to $381, sees growth ahead
    • Nio stock price forecast: why it is soaring and what next
    • Nvidia CEO Jensen Huang disappointed at China ban, acknowledges geopolitcal pressures

    About Insightful Word

    • Contacts
    • Cookie Notice
    • Privacy Policy
    • Terms of Service
    • Trading tools
    • Contacts
    • Cookie Notice
    • Privacy Policy
    • Terms of Service
    • Trading tools

    Copyright © 2025 Insightfulword.com. All Rights Reserved.

    No Result
    View All Result
    • Investing
    • Stock
    • Economy
    • Politics

    Copyright © 2025 Insightfulword.com. All Rights Reserved.